Focused Ultrasound Blood-Brain Barrier Opening in Pontine Diffuse Midline Glioma to Enhance Temozolomide Therapy: Pilot Feasibility Study (FIDES)

NCT07562971 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Midline Glioma, H3 K27-Altered

Interventions

DEVICE: Focused Ultrasound (FUS) Blood-Brain Barrier Opening
DRUG: Temozolomide (TMZ)

Sponsor

UMC Utrecht

Collaborators

[object Object]